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Editorial for special issue ‘Applications and developments in targeted proteomics: from SRM to 
DIA/SWATH’ 
 
The adaptation of targeted data acquisition from small molecule analysis to bottom-up proteomics in 
the form of selected reaction monitoring (SRM) approximately a decade ago was initially motivated 
by the need for robust and sensitive quantification of proteins in both basic life science research and 
translational medicine. This need was precipitated by limitations with respect to quantification, 
repeatability and  reproducibility that were associated with data dependent acquisition (DDA) caused 
by the now well described issues surrounding stochasticity of precursor selection1. Over the years, 
the capabilities of targeted data acquisition by SRM2, and its more recently implemented cousin 
parallel reaction monitoring3,4 (PRM) , have developed remarkably in both instrumentation and 
software, enabling robust and sensitive quantification of discrete sets of proteins across large sets of 
samples.  Further, the quality of the quantitative data available from targeted approaches and the 
robustness of the methods have enabled highly successful applications in a variety of arenas and this 
has led to broad community acceptance of the utility of targeted proteomics5. 
While targeted data acquisition by SRM or PRM has been successful, the methods are also limited in 
utility for some applications. Most obviously, data is acquired for a set of proteins, defined prior to 
acquisition and once acquired, there is no possibility to re-mine the data to obtain information for 
other targets. In principle, data independent acquisition6 (DIA) alleviated the requirement to define a 
set of proteins prior to acquisition and could expand to quantify larger sets of proteins. The 
introduction of targeted data analysis to DIA, implemented as SWATH-MS7, drew on analysis 
principles similar to those developed for data from targeted acquisition. This marked a turning point 
in DIA that facilitated the generation of data that maintained the favorable quantitative 
characteristics of targeted data acquisition, while significantly expanding the coverage of proteins 
compared to SRM or PRM. This advance has led to significant method developments in this space, in 
parallel to successful applications in many research areas. 
The term DIA has broadly referred to a range of deterministic acquisition methods8 accompanied by 
data analysis strategies9 which fall into either the peptide-centric analysis category10,11, utilizing 
targeted data analysis similar to SWATH-MS, or the spectrum-centric data analysis category, that are 
conceptually more similar to classical database search strategies. To capture the range of 
approaches, we have chosen to use the inclusive term DIA/SWATH in the title of this special issue to 
indicate that the focus here is on DIA strategies which draw on the concepts and analysis strategies 
which are characteristic of targeted proteomics (as in SWATH-MS). Furthermore, applications in 
DIA/SWATH may use terms borrowed from targeted data acquisition such as “targeted assay” or 
“library” to describe a set of analyte parameters used for data extraction from DIA data. Additional 
discussion could examine and perhaps refine these terms in the context of DIA, for example, similar 
to a recent community effort which proposed categorization of assays of various stringency levels for 
different types of basic  science or clinical applications in targeted MS measurements12. We hope this 
special issue will stimulate such a conversation in this area regarding terminology. 
The goal of this special issue was to sample the breadth of applications currently being pursued using 
these techniques as well as to represent ongoing technical developments. In the first section of the 
volume, 7 papers describe applications in the scope of the special issue. In the second section, 6 
papers review and compare different techniques and discuss differences between them. And in the 
third and final section, 5 papers suggest various developments in acquisition and data analysis. 
With these applications and developments in mind we might ask what will the future hold for 
targeted proteomics and related DIA-based methods? With the rapid increase in the scanning speed 
of high resolution mass spectrometers the lines between approaches such as PRM, DDA, and 
DIA/SWATH will begin to blur and a unified acquisition method could emerge in which high 
resolution MS2 spectra are acquired deterministically with narrow precursor isolation windows and 
comprehensive sampling of the precursor space. With such comprehensive and high quality data it 
seems likely that the focus of discussion will be whether the data should be analyzed by peptide-
centric approaches or by spectrum-centric approaches. With the availability of unprecedented data 
sets generated by these methods, the focus of quantitative proteomics might also partially shift away 
from technical aspects towards the most innovative applications of the powerful technology to 
generate new biological and clinical knowledge.    
What then is the future for targeted proteomics using low resolution mass spectrometers (e.g SRM)? 
The sensitivity, relatively low cost and robustness of triple quadrupoles will likely keep this method in 
favor for routine applications where discrete sets of proteins need to be measured in large numbers 
of samples. In particular, translating targeted assays into analytical tier 1 assays for potential future 
applications in clinical research remains an attractive prospect12. In broader terms, targeted 
proteomics using SRM/PRM for basic research purposes is also likely to persist as the level of 
sensitivity and selectivity achievable may be still favorable compared to DIA-based methods. 
We would like to thank all of the authors who contributed articles to this special issue, the reviewers 
who provided critical feedback, and the editors of PROTEOMICS for making this special issue 
possible. Based on the enthusiastic response to the call for submissions to this special issue, one 
point is clear: The interest in continuing to develop and apply methods in this area is increasing and 
there are surely exciting times ahead. We speculate that the bright line that has separated targeted 
proteomics from discovery proteomics will begin to fade leaving only a broad quantitative 
proteomics method for life science research which is robust, reproducible and comprehensive13. We 
hope that the collection of papers in this special issue will help to underscore the power and 
potential of this arena of quantitative proteomics. 
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